On Demand Webinars
Master Density measurement Quinitix® Pro - Precision Made Simple
Density Determination Made Easy with the Quintix® Pro Standard Laboratory Balance
Ultrapure Water: The Key to Reliable Laboratory Results – Webinar
As analytical methods become more sensitive, even trace impurities can compromise data accuracy and reproducibility. Consistent, high-quality lab water is essential to preventing errors and avoiding costly rework.
Discover How to Develop a Robust Extractables & Leachables Program for Your Drug
Join West expert Kwang Kok Li for an insightful discussion on Extractables and Leachables (E&L) and the best practices to support customer requirements.
QualTrak™™ qPCR & dPCR Biopharma Ecosystem
Accelerate the development and manufacturing of mRNA and protein-based vaccines by leveraging Applied Biosystems QualTrak real-time PCR and digital PCR tools for biopharma. Incorporate these highly-sensitive and accurate technologies into workflows across your pipeline for applications in gene expression, genotyping, contaminant testing, and more.
Tech Transfer Strategies and Best Practices to Optimize Your Clinical and Commercial Supply
Tech transfers for biological products, whether they occur from a pharma company, another CMO, or a different site within the same organization, are complex and challenging processes. This insightful webinar explores the critical aspects of technology transfer of either drug substance or drug product.
CMC Challenges in the Evolving Small Molecule Development Pipeline
A growing proportion of drugs in the development pipeline nowadays start out life at small biotech companies, rather than big pharma businesses.
Environmental Sustainability at Lonza Small Molecules - Wastewater Incineration Reduction
Sustainability is at the forefront of the way Lonza runs its business. Thanks to its Vision Zero initiative, it aspires to reduce emissions, water consumption and waste, as well as work without incidents.
How to Deal with the Complexity of Drugs in Clinical Development
Increasing complexity and tight timelines are putting more pressure on professionals involved in clinical drug development.
Bridging Genomics and Proteomics: Interrogation of Prospective and Archived Samples for Population- Scale Biomarker Discovery
Modern omics have redefined our understanding of biology and disease but scaling these insights to population-level studies demands innovation in automation, sensitivity, and data integration.
Decentralized Trials: The future is now
Decentralised trials are no longer a thing of the future. This session will focus on how COVID-19 pandemic presented an opportunity to re-envision clinical trials, a change that was long overdue.
